Full-Time

Quality and Safety Manager

Patient Safety & Risk Management

Posted on 10/31/2025

Ro

Ro

1,001-5,000 employees

Online telemedicine platform with prescription delivery

Compensation Overview

$130.1k - $150k/yr

+ Equity

Remote in USA + 1 more

More locations: New York, NY, USA

Hybrid

HQ visit days: NY area 2 days per week; optional on-sites for others

Category
Medical, Clinical & Veterinary (2)
,

Get referred to Ro

See people who can refer or advise you

Requirements
  • BSN or equivalent years of experience
  • Current RN licensure
  • 5+ years of experience as an RN
  • 1-2+ years of which are spent in virtual care (asynchronous is a plus)
  • 1-2+ years of experience in direct patient care
  • 1+ years focusing on patient safety
  • 1+ years focusing on risk management
  • Demonstrated experience applying data insights to enhance healthcare safety practices
  • Understanding of the principles of clinical risk management
  • Experience using clinical background to identify potential concerns for patient safety and quality of care
  • Detailed oriented and highly organized - able to make sense of unorganized data and clinical information
  • Adept at learning new technology and can thrive in a fast-paced, high-intensity environment
  • Relevant certification in patient safety or risk management (e.g., CPPS, CPHQ, ARM, CPRM) preferred
Responsibilities
  • Triage, investigate, and escalate clinical incidents reported by frontline staff; document findings, maintain accurate records, and facilitate feedback loops to ensure learning, accountability, and continuous improvement
  • Assist in the coordination and response to large-scale patient safety events requiring rapid investigation and cross-functional collaboration
  • Conduct targeted chart audits related to cautionary events and safety metrics to identify trends and areas for improvement
  • Oversee and execute monitoring processes for potential side effects, supporting proactive pharmacovigilance
  • Take a lead role in evaluating new clinical technologies, workflows, and treatment offerings to identify and quantify potential risks prior to implementation
  • Facilitate prioritization of patient safety opportunities based on risk assessment and strategic alignment
  • Drive forward team initiatives and contribute to larger cross-functional projects, with ownership of specific deliverables and outcomes
  • Communicate identified risks clearly and effectively to cross-functional teams, enabling informed decision-making and appropriate mitigation strategies
  • Support Ro’s participation in a Patient Safety Organization (PSO), including data submission and integration of learnings into safety strategy
  • Analyze safety data and trends to generate insights that inform strategic decisions, operational improvements, and clinical best practices
Desired Qualifications
  • Relevant certification in patient safety or risk management (e.g., CPPS, CPHQ, ARM, CPRM) preferred

Ro.co provides online telemedicine services for adults to manage health from home. Patients complete an online visit; US-licensed clinicians review symptoms and medical history to diagnose and recommend personalized treatment, which may include a prescription shipped directly to the patient with free shipping. The service emphasizes privacy and security, adhering to applicable laws and implementing protective measures for data. Its goal is to deliver convenient, end-to-end online care—from consultation to prescription—without in-person visits.

Company Size

1,001-5,000

Company Stage

Late Stage VC

Total Funding

$1B

Headquarters

New York City, New York

Founded

2017

Get referred to Ro

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Novo Nordisk collaboration expands affordable Wegovy access and improves conversion.
  • Ro Body memberships can increase retention through coaching, tracking, and monitoring.
  • Nationwide coverage across primary-care deserts supports growth in underserved markets.

What critics are saying

  • Novo Nordisk dependence concentrates revenue and exposes Ro to channel renegotiation.
  • Lilly pharmacy integration creates distributor dependency and weakens Ro's bargaining power.
  • GLP-1 price competition compresses margins as manufacturers and rivals undercut cash-pay offers.

What makes Ro unique

  • Nationwide direct-to-patient platform combines telehealth, labs, pharmacy, and in-home care.
  • Vertical integration enables diagnosis-to-medication delivery within one controlled care workflow.
  • GLP-1 launches and insurance tools strengthen Ro's obesity-care distribution advantage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision benefits

One Medical membership

Equity

Flexible Time Off

Gym reimbursement stipend

Learning & development stipend

Paid parental leave

Flexible work arrangements

Dog-friendly office

Company-wide events

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Ro
Mar 31st, 2026
Ro Helps Patients save up to $1,200 per year on Wegovy(R) through collaboration with Novo Nordisk.

Ro Helps Patients save up to $1,200 per year on Wegovy(R) through collaboration with Novo Nordisk. The Wegovy(R) injectable and pill are now available at even lower cash pay prices on Ro March 31, 2026 - Ro, the leading direct-to-patient healthcare company, today announced that patients can save up to $1,200/year on the Wegovy(R) pen or $600/year on the Wegovy(R) pill through its collaboration with Novo Nordisk. The new savings options (including 3, 6, and 12 month prepaid plans) enable cash paying patients to access new, lower prices available for both the Wegovy(R) pen or pill. In addition, patients will soon be able to save with new, lower price Ro Body membership options. "At Ro, we fight every day to help patients achieve their health goals - but goals don't matter if treatment isn't within reach. Affordability is access, and helping patients save up to $1,200 per year on Wegovy(R) is a meaningful step toward breaking down that barrier for millions more people," said Zach Reitano, CEO and co-founder of Ro. "Working with Novo Nordisk, we're pushing forward a new model for how life-changing GLP-1 treatments reach patients - more affordably and at scale." Since April of 2025, Ro has worked with Novo Nordisk to help more patients access FDA-approved GLP-1 medications at the best available cash prices. Most recently, Ro launched Novo's new Wegovy(R) pill on its direct-to-patient platform - making the pill an option to patients nationwide on day one of its market availability. This first-of-its-kind drug launch helped meet the incredible demand for the only FDA-approved oral GLP-1 weight loss medication and make it one of the most successful launches ever. "More and more people are turning to direct-to-patient channels like Ro that seamlessly offer FDA-approved medicines and weight loss support with a convenient, end-to-end experience. By introducing new subscription pricing for Wegovy(R) at our lowest prices, we're giving people even more control over their care journey, with transparent payment options that fit their individual needs," said Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk. In April, Ro will also introduce new options offering significant savings for the Body membership, enabling patients access to high-quality ongoing care, 24/7 messaging, progress tracking and side effect monitoring, and 1-1 coaching. For those who want to check their insurance coverage, Ro's GLP-1 Insurance Checker has helped over 2 million people understand their benefits, so they can get their medication at the lowest possible price - whether that's using insurance coverage or paying cash. See Important Safety Information about GLP-1 medications, including Boxed Warning, at ro.co/safety. About ro. Ro is a direct-to-patient healthcare company with a mission of helping patients achieve their health goals by delivering the easiest, most effective care possible. Ro is the only company to offer nationwide telehealth, labs, and pharmacy services. This is enabled by Ro's vertically integrated platform that helps patients achieve their goals through a convenient, end-to-end healthcare experience spanning from diagnosis, to delivery of medication, to ongoing care. Since 2017, Ro has helped millions of patients in nearly every single county in the United States, including 99% of primary care deserts. Visit Ro.co for more information. See more news from ro. Ro Debuts First-Ever Super Bowl Commercial Starring Serena Williams to Launch "Healthier on Ro" Campaign Ro Announces Research Collaboration to Better Understand and Improve the Real-World Patient Experience with GLP-1s Ro Launches Wegovy(R) Pill Through Integration with Novo Nordisk New Research Shows Ro Helps Patients Achieve Weight Loss and Safety Outcomes Consistent with Clinical Trials Ro to Present Eight Research Abstracts at ObesityWeek 2025 Ro Collaborates with Leading Obesity Researchers to Debut New, Validated Scale to Measure 'Food Noise' Serena Williams joins Ro as GLP-1 Celebrity Ambassador Ro introduces one-month $199 Wegovy(R) new patient offer and discounted Body membership Charles Barkley partners with Ro as GLP-1 celebrity ambassador Ro integrates with NovoCare(R) Pharmacy to provide seamless access to Wegovy(R) at the lowest cash price Ro works with Lilly to streamline patient access to authentic Zepbound(R) single-dose vials by integrating with Lilly's pharmacy channel

Femtech Insider
Aug 22nd, 2025
Serena Williams Partners with Ro as GLP-1 Weight Loss Ambassador

Tennis champion Serena Williams has joined direct-to-patient healthcare company Ro as a celebrity patient ambassador for GLP-1 weight loss medications.

PR Newswire
May 22nd, 2025
Ro Introduces One-Month $199 Wegovy New Patient Offer And Discounted Body Membership

Patients can come to Ro for the lowest cost FDA-approved GLP-1s anywhereNEW YORK, May 22, 2025 /PRNewswire/ -- Ro today announced it is offering Novo Nordisk's first month discounted cash price of $199 for Wegovy® for new patients. Ro is able to offer this promotion immediately through its seamless integration with Novo Nordisk's direct-to-patient option NovoCare® Pharmacy

Forbes
May 5th, 2025
Charles Barkley On Getting Fit: 'Let'S Get To Work!'

Charles Barkley attends 2024 Steve Harvey Charity Golf Classic at Bear's Best Atlanta on June 05,. More 2024 in Suwanee, Georgia. (Photo by Paras Griffin/Getty Images) Getty ImagesGetting fit has not only been an ongoing struggle for many Americans, but it’s almost part of the American way of life. Recently, with the emergence of more advanced weight loss remedies, there are more options and perhaps more hope for adults who have long battled obesity during their adulthood.And it might seem that everyone is talking about GLP-1. This relatively new medication can help manage Type 2 diabetes and obesity by regulating appetite by slowing down digestion and promoting a feeling of fullness after eating. But for those who don’t really follow science, or what celebrities are doing to keep most fit, all the acronyms and medical terminology can be daunting.Enter Charles Barkley, the NBA Hall of Famer and sports media talking head, who is also known for his voiceover work on many a TV commercial

PYMNTS
Aug 8th, 2024
Fabric Buys Walmart’S Telehealth Business And Stitches Ai Into Digital Healthcare

Telehealth has evolved from a niche service to a central element of healthcare, a shift accelerated by the COVID-19 pandemic. This evolution reflects a broader move toward digital health solutions that fundamentally change patient care. “We’re creating that on-demand experience for patients to get care through a more omnichannel lens,” Aniq Rahman, founder and CEO of Fabric, explained to PYMNTS in an interview. “We want to give great care virtually so people don’t have to leave their homes.”. Fabric’s care enablement system integrates virtual and in-person services through conversational AI and adaptive interviews. This system, designed by clinicians, enhances care quality, accelerates workflows up to tenfold, reduces call center volume by 15%, and improves appointment slot utilization

INACTIVE